KMT2A and acute myeloid leukemia: In this work, we present the OGM analysis of 38 AML samples: 12 cryptic or hard-to-characterize KMT2A fusions, 20 KMT2A-PTD cases as well as 6 AMLs with no evidence of any KMT2A anomaly.